G. Vennarecci
Research Subjects
Research Interests
G. Vennarecci has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
R. Santoro
8 shared publications- Giuseppe Maria Ettorre
Department of Surgery, San Camillo Forlanini Hospital, 00152 Rome, Italy
6 shared publications - Mario Antonini
Anesthesiology and Intensive Care Unit, National Institute for Infectious Disease "L. Spallanzani", Rome, Italy
4 shared publications E. Santoro
3 shared publicationsG.M. Ettorre
3 shared publicationsL. Miglioresi
3 shared publications
Latest Publications
- 1 November 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (9) , 3314-3315
Hanging of the Hepatic Veins Septa: A Safe Control Prior and During Outflow Anastomosis in Liver Transplantation
- 1 November 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (9) , 3314-3315
Hanging of the Hepatic Veins Septa: A Safe Control Prior and During Outflow Anastomosis in Liver Transplantation
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 567
Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 567
Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study
- 30 April 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S88
206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS
- 30 April 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S88
206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS
- 28 February 2011
- Published by Elsevier in Digestive and Liver Disease
- Vol. 43, S107
F-48 HCV relapses occur within 3 months after treatment in liver transplanted patients receiving pegylated IFN and ribavirin
- 28 February 2011
- Published by Elsevier in Digestive and Liver Disease
- Vol. 43, S107
F-48 HCV relapses occur within 3 months after treatment in liver transplanted patients receiving pegylated IFN and ribavirin
- 27 July 2010
- Published by Wolters Kluwer Health in Transplantation
- Vol. 90, 706
DE NOVO TUMORS AFTER LIVER TRANSPLANTATION: RESULTS FROM A MULTICENTRIC STUDY, ITALY 1990–2008.
- 27 July 2010
- Published by Wolters Kluwer Health in Transplantation
- Vol. 90, 706
DE NOVO TUMORS AFTER LIVER TRANSPLANTATION: RESULTS FROM A MULTICENTRIC STUDY, ITALY 1990–2008.
- 30 April 2010
- Published by Elsevier in Journal of Hepatology
- Vol. 52, S80
186 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: SAFETY AND EFFICACY OF LOW DOSAGE OF ENOXAPARIN
- 30 April 2010
- Published by Elsevier in Journal of Hepatology
- Vol. 52, S80
186 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: SAFETY AND EFFICACY OF LOW DOSAGE OF ENOXAPARIN
- 1 May 2009
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (5) , A13
survivin-IgM immuno complex: A novel candidate biomarker of cirrhosis to monitor patients progression towards hepatocellular carcinoma
- 1 May 2009
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (5) , A13
survivin-IgM immuno complex: A novel candidate biomarker of cirrhosis to monitor patients progression towards hepatocellular carcinoma
- 1 December 2007
- Vol. 26 (4) , 603-7
Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature.
Insulin-secreting tumors are the commonest hormone-producing neoplasm of the gastrointestinal tract. They occur with an incidence of 4 cases per million per year. About 10% of them are metastatic and malignant insulinomas very rarely observed in children and in elderly. We report a rare case of very large malignant insulinoma in a 71-year-old woman admitted in our Oncological Institute on October 2005. She presented with fasting hypoglicemia (blood glucose 35 mg/dl) and high serum insulin levels (insulin 115.9 microU/ml). A computerized tomographic scan showed a pancreatic tail lesion of about 6 cm in max diameter and multiple liver metastases. A whole body scintiscan using 111In-DTPA-D-Phe1-octreotide was made and an increased uptake in the tail of the pancreas has been found. The patient was submitted to liver biopsy and the diagnosis of a metastatic insulin-secreting tumor was immunoistochemically confirmed. Due to the presence of some hypoglicemic episodes uncontrolled by medical treatment, on December 2005 the patient was admitted to surgical intervention with a body and tail pancreatic resection. Post-operatively the patient experienced again syncope with hypoglycemia and hyperinsulinemia. It was then decided to start a schedule of treatment with somatostatin analog (octreotide subcutaneously 500 microg three times a day) with a good control of blood glucose levels (101 mg/dl). A trans-arterial chemioembolization was planned but the patient died for pancreatic and cardiovascular complications before this treatment started.
- 1 December 2007
- Vol. 26 (4) , 603-7
Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature.
Insulin-secreting tumors are the commonest hormone-producing neoplasm of the gastrointestinal tract. They occur with an incidence of 4 cases per million per year. About 10% of them are metastatic and malignant insulinomas very rarely observed in children and in elderly. We report a rare case of very large malignant insulinoma in a 71-year-old woman admitted in our Oncological Institute on October 2005. She presented with fasting hypoglicemia (blood glucose 35 mg/dl) and high serum insulin levels (insulin 115.9 microU/ml). A computerized tomographic scan showed a pancreatic tail lesion of about 6 cm in max diameter and multiple liver metastases. A whole body scintiscan using 111In-DTPA-D-Phe1-octreotide was made and an increased uptake in the tail of the pancreas has been found. The patient was submitted to liver biopsy and the diagnosis of a metastatic insulin-secreting tumor was immunoistochemically confirmed. Due to the presence of some hypoglicemic episodes uncontrolled by medical treatment, on December 2005 the patient was admitted to surgical intervention with a body and tail pancreatic resection. Post-operatively the patient experienced again syncope with hypoglycemia and hyperinsulinemia. It was then decided to start a schedule of treatment with somatostatin analog (octreotide subcutaneously 500 microg three times a day) with a good control of blood glucose levels (101 mg/dl). A trans-arterial chemioembolization was planned but the patient died for pancreatic and cardiovascular complications before this treatment started.
- 1 July 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (6) , 1936-1938
Liver Transplantation in HIV-Positive Patients
- 1 July 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (6) , 1936-1938
Liver Transplantation in HIV-Positive Patients
- 1 July 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (6) , 1857-1860
First-Line Liver Resection and Salvage Liver Transplantation Are Increasing Therapeutic Strategies for Patients With Hepatocellular Carcinoma and Child A Cirrhosis
- 1 July 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (6) , 1857-1860
First-Line Liver Resection and Salvage Liver Transplantation Are Increasing Therapeutic Strategies for Patients With Hepatocellular Carcinoma and Child A Cirrhosis